The human experience with ghrelin administration

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 5, 2013, Pages 1826-1837

  Garin, Margaret C ^a   Burns, Carrie M ^a   Kaul, Shailja ^a   Cappola, Anne R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CORTICOTROPIN; ESTRADIOL; FOLLITROPIN; GESTAGEN; GHRELIN; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; HYPOPHYSIS HORMONE; LUTEINIZING HORMONE; PLACEBO; PROLACTIN; PROTIRELIN; SOMATOSTATIN; THYROTROPIN; APPETITE STIMULANT; GHRL PROTEIN, HUMAN; HUMAN GROWTH HORMONE; RECOMBINANT PROTEIN;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ACROMEGALY; ANOREXIA NERVOSA; APPETITE; ARTICLE; BODY COMPOSITION; BULIMIA; CACHEXIA; CALORIC INTAKE; CUSHING SYNDROME; DEPRESSION; DIABETES MELLITUS; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; DYSPEPSIA; DYSPNEA; ENTERITIS; ESOPHAGUS CANCER; FATIGUE; FLUSHING; GASTRECTOMY; GASTRIC RUMBLES; GASTRIN BLOOD LEVEL; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL SYMPTOM; GLUCOSE HOMEOSTASIS; GLUCOSURIA; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HUMAN; HYPERPARATHYROIDISM; HYPERTHYROIDISM; HYPOPITUITARISM; HYPOPROTEINEMIA; HYPOTENSION; KIDNEY DISEASE; LIPOLYSIS; LIVER FUNCTION TEST; LOW DRUG DOSE; LUNG CANCER; LUNG DISEASE; LUNG FUNCTION; MAJOR DEPRESSION; MALIGNANT NEOPLASTIC DISEASE; METABOLIC SYNDROME X; MOOD DISORDER; NAUSEA; NEUROPATHY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OSTEOARTHRITIS; OVARY POLYCYSTIC DISEASE; PNEUMONIA; PRIORITY JOURNAL; REPEATED DRUG DOSE; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; SIDE EFFECT; SINGLE DRUG DOSE; SLEEP PATTERN; SOMNOLENCE; STOMACH EMPTYING; STOMACH PARESIS; SWEATING; SYSTEMATIC REVIEW; VERTIGO; VOMITING; XEROSTOMIA; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG POTENTIATION; GASTROINTESTINAL DISEASE; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; REVIEW; SEVERITY OF ILLNESS INDEX;

APPETITE STIMULANTS; ENERGY INTAKE; FLUSHING; GASTROINTESTINAL DISEASES; GHRELIN; HUMAN GROWTH HORMONE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX;

MLCS; MLOWN;

EID: 84877701181     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4247     Document Type: Article

References (131)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-660.
2. Smith RG, Van der Ploeg LH, Howard AD, et al. Peptidomimetic regulation of growth hormone secretion. Endocr Rev. 1997;18:621-645.
3. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255-4261.
4. Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002;87:2988.
5. Banks WA, Tschop M, Robinson SM, Heiman ML. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther. 2002;302:822-827.
6. Takaya K, Ariyasu H, Kanamoto N, et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab. 2000;85:4908-4911.
7. Arvat E, Maccario M, Di Vito L, et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab. 2001;86: 1169-1174.
8. Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 2000;141:4325-4328.
9. Broglio F, Gottero C, Benso A, et al. Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans. J Clin Endocrinol Metab. 2003;88:4268-4272.
10. Thompson NM, Gill DA, Davies R, et al. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology. 2004;145:234-242.
11. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001;409:194-198.
12. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908-913.
13. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. Apreprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50:1714-1719.
14. Maghnie M, Pennati MC, Civardi E, et al. GH response to ghrelin in subjects with congenital GH deficiency: evidence that ghrelin action requires hypothalamic-pituitary connections. Eur J Endocrinol. 2007;156:449-454.
15. Nagaya N, Moriya J, Yasumura Y, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation. 2004; 110:3674-3679.
16. Nagaya N, Itoh T, Murakami S, et al. Treatment of cachexia with ghrelin in patients with COPD. Chest. 2005;128:1187-1193.
17. Akamizu T, Iwakura H, Ariyasu H, et al. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur J Endocrinol. 2008;158:491-498.
18. Kodama T, Ashitani J, Matsumoto N, Kangawa K, Nakazato M. Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection. Pulm Pharmacol Ther. 2008;21:774-779.
19. Hotta M, Ohwada R, Akamizu T, Shibasaki T, Takano K, Kangawa K. Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study. Endocr J. 2009;56: 1119-1128.
20. Adachi S, Takiguchi S, Okada K, et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebocontrolled phase II study. Gastroenterology. 2010;138:1312-1320.
21. Yamamoto K, Takiguchi S, Miyata H, et al. Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction. Surgery. 2010;148:31-38.
22. Hiura Y, Takiguchi S, Yamamoto K, et al. Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients. Int J Clin Oncol. 2012;17:316-323.
23. Miki K, Maekura R, Nagaya N, et al. Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial. PLoS One. 2012;7:e35708.
24. Tesauro M, Schinzari F, Iantorno M, et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation. 2005;112:2986-2992.
25. Tesauro M, Schinzari F, Rovella V, et al. Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome. Hypertension. 2009;54:995-1000.
26. Vestergaard ET, Buhl M, Gjedsted J, et al. Acute peripheral metabolic effects of intraarterial ghrelin infusion in healthy young men. J Clin Endocrinol Metab. 2011;96:468-477.
27. Togliatto G, Trombetta A, Dentelli P, et al. Unacylated ghrelin rescues endothelial progenitor cell function in individuals with type 2 diabetes. Diabetes. 2010;59:1016-1025.
28. Benso A, St-Pierre DH, Prodam F, et al. Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. Eur J Endocrinol. 2012;166:911-916.
29. Enomoto M, Nagaya N, Uematsu M, et al. Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans. Clin Sci (Lond). 2003;105:431-435.
30. Wynne K, Giannitsopoulou K, Small CJ, et al. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol. 2005;16:2111-2118.
31. Druce MR, Neary NM, Small CJ, et al. Subcutaneous administration of ghrelin stimulates energy intake in healthy lean human volunteers. Int J Obes (Lond). 2006;30:293-296.
32. Ashby DR, Ford HE, Wynne KJ, et al. Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int. 2009;76:199-206.
33. Lundholm K, Gunnebo L, Korner U, et al. Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study. Cancer. 2010;116:2044-2052.
34. Okumura H, Nagaya N, Enomoto M, Nakagawa E, Oya H, Kangawa K. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol. 2002;39:779-783.
35. Gauna C, Meyler FM, Janssen JA, et al. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab. 2004;89:5035-5042.
36. Kiewiet RM, van Aken MO, van der Weerd K, et al. Effects of acute administration of acylated and unacylated ghrelin on glucose and insulin concentrations in morbidly obese subjects without overt diabetes. Eur J Endocrinol. 2009;161:567-573.
37. Akamizu T, Takaya K, Irako T, et al. Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol. 2004;150:447-455.
38. Nagaya N, Kojima M, Uematsu M, et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1483-R1487.
39. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001; 86:5992.
40. Druce MR, Wren AM, Park AJ, et al. Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond). 2005;29:1130-1136.
41. Schmid DA, Held K, Ising M, Uhr M, Weikel JC, Steiger A. Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls. Neuropsychopharmacology. 2005;30:1187-1192.
42. Neary NM, Small CJ, Wren AM, et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:2832-2836.
43. Huda MS, Dovey T, Wong SP, et al. Ghrelin restores 'lean-type' hunger and energy expenditure profiles in morbidly obese subjects but has no effect on postgastrectomy subjects. Int J Obes (Lond). 2009;33:317-325.
44. le Roux CW, Neary NM, Halsey TJ, et al. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab. 2005;90:4521-4524.
45. Miljic D, Pekic S, Djurovic M, et al. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. J Clin Endocrinol Metab. 2006;91: 1491-1495.
46. Coiro V, Saccani-Jotti G, Rubino P, Manfredi G, Melani A, Chiodera P. Effects of ghrelin on circulating neuropeptide Y levels in humans. Neuro Endocrinol Lett. 2006;27:755-757.
47. Coiro V, Saccani-Jotti G, Rubino P, et al. Oxytocin inhibits the stimulatory effect of ghrelin on circulating neuropeptide Y levels in humans. J Neural Transm. 2008;115:1265-1267.
48. Akamizu T, Iwakura H, Ariyasu H, et al. Effects of ghrelin treatment on patients undergoing total hip replacement for osteoarthritis: different outcomes from studies in patients with cardiac and pulmonary cachexia. J Am Geriatr Soc. 2008;56:2363-2365.
49. Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000;276:905-908.
50. Cremonini F, Camilleri M, Vazquez Roque M, et al. Obesity does not increase effects of synthetic ghrelin on human gastric motor functions. Gastroenterology. 2006;131:1431-1439.
51. Levin F, Edholm T, Schmidt PT, et al. Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab. 2006;91:3296-3302.
52. Murray CD, Martin NM, Patterson M, et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut. 2005;54:1693-1698.
53. Binn M, Albert C, Gougeon A, et al. Ghrelin gastrokinetic action in patients with neurogenic gastroparesis. Peptides. 2006;27:1603-1606.
54. Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther. 2005;22:847-853.
55. Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut. 2006;55: 327-333.
56. Ang D, Nicolai H, Vos R, et al. Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in man. Neurogastroenterol Motil. 2009;21:528-533:e8-e9.
57. Falken Y, Hellstrom PM, Sanger GJ, et al. Actions of prolonged ghrelin infusion on gastrointestinal transit and glucose homeostasis in humans. Neurogastroenterol Motil. 2010;22:e192-e200.
58. Mori M, Suzuki H, Masaoka T, et al. Intravenous ghrelin administration enhances gastric acid secretion-evaluation using wireless pH capsule. Aliment Pharmacol Ther Sympos Ser. 2006;2:96-103.
59. Vestergaard ET, Andersen NH, Hansen TK, et al. Cardiovascular effects of intravenous ghrelin infusion in healthy young men. Am J Physiol Heart Circ Physiol. 2007;293:H3020-H3026.
60. Nagaya N, Miyatake K, Uematsu M, et al. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J Clin Endocrinol Metab. 2001;86:5854-5859.
61. Janssen JA, Poldermans D, Hofland LJ, et al. There are no acute cardiac effects of a single iv dose of human ghrelin in severe growth hormone deficient patients. J Endocrinol Invest. 2004;27:659-664.
62. Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Messinis IE. Growth hormone and prolactin response to ghrelin during the normal menstrual cycle. Clin Endocrinol (Oxf). 2009;71:383-387.
63. Peino R, Baldelli R, Rodriguez-Garcia J, et al. Ghrelin-induced growth hormone secretion in humans. Eur J Endocrinol. 2000;143: R11-R14.
64. Hataya Y, Akamizu T, Takaya K, et al. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab. 2001;86: 4552.
65. Veldhuis JD, Reynolds GA, Iranmanesh A, Bowers CY. Twentyfour hour continuous ghrelin infusion augments physiologically pulsatile, nycthemeral, and entropic (feedback-regulated) modes of growth hormone secretion. J Clin Endocrinol Metab. 2008;93: 3597-3603.
66. Tong J, D'Alessio D, Ramisch J, et al. Ghrelin stimulation of growth hormone isoforms: parallel secretion of total and 20-kDa growth hormone and relation to insulin sensitivity in healthy humans. J Clin Endocrinol Metab. 2012;97:3366-3374.
67. de Sá LB, Nascif SO, Correa-Silva SR, et al. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus. Metabolism. 2010; 59:1536-1542.
68. Takeno R, Okimura Y, Iguchi G, et al. Intravenous administration of ghrelin stimulates growth hormone secretion in vagotomized patients as well as normal subjects. Eur J Endocrinol. 2004;151:447-450.
69. Popovic V, Miljic D, Pekic S, et al. Low plasma ghrelin level in gastrectomized patients is accompanied by enhanced sensitivity to the ghrelin-induced growth hormone release. J Clin Endocrinol Metab. 2005;90:2187-2191.
70. Tassone F, Broglio F, Destefanis S, et al. Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. J Clin Endocrinol Metab. 2003;88:5478-5483.
71. Alvarez-Castro P, Isidro ML, Garcia-Buela J, et al. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients. Clin Endocrinol (Oxf). 2004;61: 250-255.
72. Fusco A, Bianchi A, Mancini A, et al. Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome. J Endocrinol Invest. 2007;30:948-956.
73. Broglio F, Gianotti L, Destefanis S, et al. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin Endocrinol (Oxf). 2004;60:592-599.
74. Nascif SO, Correa-Silva SR, Silva MR, Lengyel AM. Decreased ghrelin-induced GH release in thyrotoxicosis: comparison with GH releasing peptide-6 (GHRP-6) and GHRH. Pituitary. 2007;10:27-33.
75. Molica P, Nascif SO, Correa-Silva SR, de Sa LB, Vieira JG, Lengyel AM. Effects of ghrelin, GH-releasing peptide-6 (GHRP-6) and GHRH on GH, ACTH and cortisol release in hyperthyroidism before and after treatment. Pituitary. 2010;13:315-323.
76. Correa-Silva SR, Nascif SO, Lengyel AM. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH. Pituitary. 2006;9:101-107.
77. Cecconi E, Bogazzi F, Morselli LL, et al. Primary hyperparathyroidism is associated with marked impairment of GH response to acylated ghrelin. Clin Endocrinol (Oxf). 2008;69:197-201.
78. Huda MS, Durham BH, Wong SP, et al. Lack of an acute effect of ghrelin on markers of bone turnover in healthy controls and postgastrectomy subjects. Bone. 2007;41:406-413.
79. Huda MS, Dovey TM, Wong SP, et al. Ghrelin does not orchestrate the metabolic changes seen in fasting but has significant effects on lipid mobilisation and substrate utilisation. Eur J Endocrinol. 2011; 165:45-55.
80. Popovic V, Miljic D, Micic D, et al. Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level. J Clin Endocrinol Metab. 2003;88:3450-3453.
81. Gasco V, Beccuti G, Baldini C, et al. Acylated ghrelin as provocative test for the diagnosis of GH deficiency in adults. Eur J Endocrinol. 2012;168:23-30
82. Arvat E, Di Vito L, Broglio F, et al. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest. 2000;23:493-495.
83. Broglio F, Benso A, Gottero C, et al. Effects of glucose, free fattyacids or arginine load on the GH-releasing activity of ghrelin in humans. Clin Endocrinol (Oxf). 2002;57:265-271.
84. Veldhuis JD. Sex steroids, GHRH, somatostatin, IGF-1, and IGFBP-1 modulate ghrelin's dose-dependent drive of pulsatile GH secretion in healthy older men. J Clin Endocrinol Metab. 2012;97: 4753-4760.
85. Di Vito L, Broglio F, Benso A, et al. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans. Clin Endocrinol (Oxf). 2002;56:643-648.
86. Iranmanesh A, Carpenter PC, Mielke K, Bowers CY, Veldhuis JD. Putative somatostatin suppression potentiates adrenocorticotropin secretion driven by ghrelin and human corticotropin-releasing hormone. J Clin Endocrinol Metab. 2007;92:3653-3659.
87. Arosio M, Ronchi CL, Gebbia C, Cappiello V, Beck-Peccoz P, Peracchi M. Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. J Clin Endocrinol Metab. 2003; 88:701-704.
88. Arosio M, Ronchi CL, Gebbia C, et al. Ghrelin administration affects circulating pituitary and gastro-entero-pancreatic hormones in acromegaly. Eur J Endocrinol. 2004;150:27-32.
89. Maier C, Schaller G, Buranyi B, et al. The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans. J Clin Endocrinol Metab. 2004;89:4729-4733.
90. Broglio F, Gottero C, Benso A, et al. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans. Clin Endocrinol (Oxf). 2003;58:92-98.
91. Coiro V, Volpi R, Stella A, Cataldo S, Chiodera P. Oxytocin does not modify GH, ACTH, cortisol and prolactin responses to ghrelin in normal men. Neuropeptides. 2011;45:139-142.
92. Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Anifandis G, Messinis IE. Effect of ghrelin and metoclopramide on prolactin secretion in normal women. J Endocrinol Invest. 2011;34:276-279.
93. Benso A, Gramaglia E, Prodam F, et al. β-Adrenergic agonism does not impair the GH response to acylated ghrelin in humans. Clin Endocrinol (Oxf). 2009;71:234-236.
94. Veldhuis JD, Keenan DM, Iranmanesh A, Mielke K, Miles JM, Bowers CY. Estradiol potentiates ghrelin-stimulated pulsatile growth hormone secretion in postmenopausal women. J Clin Endocrinol Metab. 2006;91:3559-3565.
95. Villa P, Costantini B, Perri C, Suriano R, Ricciardi L, Lanzone A. Estro-progestin supplementation enhances the growth hormone secretory responsiveness to ghrelin infusion in postmenopausal women. Fertil Steril. 2008;89:398-403.
96. Kok P, Paulo RC, Cosma M, et al. Estrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women. J Clin Endocrinol Metab. 2008;93:4020-4026.
97. Broglio F, Benso A, Castiglioni C, et al. The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J Clin Endocrinol Metab. 2003;88:1537-1542.
98. Fassino S, Daga GA, Mondelli V, et al. Hormonal and metabolic responses to acute ghrelin administration in patients with bulimia nervosa. Psychoneuroendocrinology. 2005;30:534-540.
99. Vestergaard ET, Hansen TK, Gormsen LC, et al. Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects. Am J Physiol Endocrinol Metab. 2007; 292:E1829-E1836.
100. Lucidi P, Murdolo G, Di Loreto C, et al. Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations. Nutr Metab Cardiovasc Dis. 2005;15:410-417.
101. Kluge M, Schussler P, Uhr M, Yassouridis A, Steiger A. Ghrelin suppresses secretion of luteinizing hormone in humans. J Clin Endocrinol Metab. 2007;92:3202-3205.
102. Kluge M, Uhr M, Bleninger P, Yassouridis A, Steiger A. Ghrelin suppresses secretion of FSH in males. Clin Endocrinol (Oxf). 2009; 70:920-923.
103. Lanfranco F, Bonelli L, Baldi M, Me E, Broglio F, Ghigo E. Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis. J Clin Endocrinol Metab. 2008;93:3633-3639.
104. Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Messinis IE. Effect of ghrelin on gonadotrophin secretion in women during the menstrual cycle. Hum Reprod. 2009;24:976-981.
105. Kluge M, Schussler P, Schmidt D, Uhr M, Steiger A. Ghrelin suppresses secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in women. J Clin Endocrinol Metab. 2012; 97:E448-E451.
106. Kluge M, Riedl S, Uhr M, et al. Ghrelin affects the hypothalamuspituitary-thyroid axis in humans by increasing free thyroxine and decreasing TSH in plasma. Eur J Endocrinol. 2010;162:1059-1065.
107. Nascif SO, Molica P, Correa-Silva SR, Silva MR, Lengyel AM. Ghrelin and GHRP-6-induced ACTH and cortisol release in thyrotoxicosis. Pituitary. 2009;12:315-321.
108. Miljic D, Joksimovic M, Doknic M, et al. ACTH and cortisol responses to ghrelin and desmopressin in patients with Cushing's disease and adrenal enlargement. J Endocrinol Invest. 2010;33: 526-529.
109. Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Anifandis G, Messinis IE. Effect of ghrelin and thyrotropin-releasing hormone on prolactin secretion in normal women. Horm Metab Res. 2010;42:204-208.
110. Alvarez-Castro P, Isidro ML, Garcia-Buela J, Dieguez C, Casanueva FF, Cordido F. Effect of acute ghrelin administration on glycaemia and insulin levels in obese patients. Diabetes Obes Metab. 2006;8:555-560.
111. Broglio F, Arvat E, Benso A, et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab. 2001; 86:5083-5086.
112. Guido M, Romualdi D, De Marinis L, et al. Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin. Fertil Steril. 2007;88:125-130.
113. Strasser F, Lutz TA, Maeder MT, et al. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. Br J Cancer. 2008;98:300-308.
114. Miljic D, Djurovic M, Pekic S, et al. Glucose metabolism during ghrelin infusion in patients with anorexia nervosa. J Endocrinol Invest. 2007;30:771-775.
115. Vestergaard ET, Gormsen LC, Jessen N, et al. Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes. 2008;57:3205-3210.
116. Vestergaard ET, Djurhuus CB, Gjedsted J, et al. Acute effects of ghrelin administration on glucose and lipid metabolism. J Clin Endocrinol Metab. 2008;93:438-444.
117. Damjanovic SS, Lalic NM, Pesko PM, et al. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients. J Clin Endocrinol Metab. 2006;91:2574-2581.
118. Broglio F, Prodam F, Riganti F, et al. The continuous infusion of acylated ghrelin enhances growth hormone secretion and worsens glucose metabolism in humans. J Endocrinol Invest. 2008;31:788-794.
119. Tong J, Prigeon RL, Davis HW, et al. Ghrelin suppresses glucosestimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes. 2010;59:2145-2151.
120. St-Pierre DH, Benso A, Gramaglia E, et al. The metabolic response to the activation of the β-adrenergic receptor by salbutamol is amplified by acylated ghrelin. J Endocrinol Invest. 2010;33:363-367.
121. Weikel JC, Wichniak A, Ising M, et al. Ghrelin promotes slow-wave sleep in humans. Am J Physiol Endocrinol Metab. 2003;284: E407-E415.
122. Kluge M, Schussler P, Bleninger P, et al. Ghrelin alone or co-administered with GHRH or CRH increases non-REM sleep and decreases REM sleep in young males. Psychoneuroendocrinology. 2008;33:497-506.
123. Kluge M, Gazea M, Schussler P, et al. Ghrelin increases slow wave sleep and stage 2 sleep and decreases stage 1 sleep and REM sleep in elderly men but does not affect sleep in elderly women. Psychoneuroendocrinology. 2010;35:297-304.
124. Kluge M, Schussler P, Zuber V, et al. Ghrelin enhances the nocturnal secretion of cortisol and growth hormone in young females without influencing sleep. Psychoneuroendocrinology. 2007;32: 1079-1085.
125. Kluge M, Schussler P, Zuber V, Yassouridis A, Steiger A. Ghrelin administered in the early morning increases secretion of cortisol and growth hormone without affecting sleep. Psychoneuroendocrinology. 2007;32:287-292.
126. Kluge M, Schussler P, Dresler M, et al. Effects of ghrelin on psychopathology, sleep and secretion of cortisol and growth hormone in patients with major depression. J Psychiatr Res. 2011;45:421-426.
127. Huda MS, Mani H, Dovey T, et al. Ghrelin inhibits autonomic function in healthy controls, but has no effect on obese and vagotomized subjects. Clin Endocrinol (Oxf). 2010;73:678-685.
128. Krapalis AF, Reiter J, Machleidt F, et al. Ghrelin modulates baroreflex-regulation of sympathetic vasomotor tone in healthy humans. Am J Physiol Regul Integr Comp Physiol. 2012;302:R1305-R1312.
129. Lambert E, Lambert G, Ika-Sari C, et al. Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men. Hypertension. 2011;58:43-50.
130. Tong J, Mannea E, Aime P, et al. Ghrelin enhances olfactory sensitivity and exploratory sniffing in rodents and humans. J Neurosci. 2011;31:5841-5846.
131. Wiedmer P, Strasser F, Horvath TL, et al. Ghrelin-induced hypothermia: a physiological basis but no clinical risk. Physiol Behav. 2011;105:43-51.